U.S. markets closed
  • S&P 500

    3,390.68
    -10.29 (-0.30%)
     
  • Dow 30

    27,463.19
    -222.19 (-0.80%)
     
  • Nasdaq

    11,431.35
    +72.41 (+0.64%)
     
  • Russell 2000

    1,590.71
    -14.50 (-0.90%)
     
  • Crude Oil

    39.24
    +0.68 (+1.76%)
     
  • Gold

    1,909.40
    +3.70 (+0.19%)
     
  • Silver

    24.50
    +0.08 (+0.35%)
     
  • EUR/USD

    1.1823
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    0.7780
    -0.0230 (-2.87%)
     
  • GBP/USD

    1.3058
    +0.0037 (+0.28%)
     
  • USD/JPY

    104.4400
    -0.3950 (-0.38%)
     
  • BTC-USD

    13,661.96
    +554.73 (+4.23%)
     
  • CMC Crypto 200

    270.43
    +9.14 (+3.50%)
     
  • FTSE 100

    5,728.99
    -63.02 (-1.09%)
     
  • Nikkei 225

    23,485.80
    -8.54 (-0.04%)
     

Correction: Financial Markets-Stocks story

NEW YORK (AP) — In a story September 29, 2020, which included information about Myovant Sciences’ potential prostate cancer drug, The Associated Press erroneously reported that the drug failed to meet multiple goals in a study. The drug failed to meet one of its goals within a broader late-stage study.